We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Liming Zhang
Liming Zhang
Products
PRODUCTS
Sanitor Corp.
Hung H. Do
,
Khoa Nathan V. Tran
,
Liming Zhang
, and
Wenzheng Zhang
Price:
$117.00
View
Health Plus Inc.
Liming Zhang
Price:
$117.00
View
Blaine Labs, Inc.
Cecilia H. Kieu
and
Liming Zhang
Price:
$117.00
View
Colonial Dames Co., Ltd.
Liming Zhang
Price:
$117.00
View
Bausch & Lomb Irvine
Liming Zhang
Price:
$117.00
View
McKenna Labs, Inc.
Liming Zhang
Price:
$117.00
View
Anidro Do Brasil Extracoes, S.A.
Liming Zhang
Price:
$117.00
View
Blaine Labs, Inc.
Liming Zhang
Price:
$117.00
View
Tec Laboratories, Inc.
Liming Zhang
Price:
$117.00
View
Cambridge Major Laboratories Europe B.V.
Liming Zhang
Price:
$117.00
View
View All Products by Liming Zhang
Upcoming Events
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
CBER’s Marks Calls for Accelerated Approval in Gene Therapies for Rare Diseases
FDA Launches Next Gen Home Healthcare Device Development Program
Senate HELP Committee, Sanders Investigating Novo Nordisk Price Gouging in US
Philips Gets Warning Letter for CT Manufacturing Site in China
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More